Cargando…
Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
Cerebellar ataxia is a frequent and often disabling syndrome severely impairing motor functioning and quality of life. Patients suffer from reduced mobility, and restricted autonomy, experiencing an even lower quality of life than, e.g., stroke survivors. Aminopyridines have been demonstrated viable...
Autores principales: | Kalla, Roger, Strupp, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341500/ https://www.ncbi.nlm.nih.gov/pubmed/30182858 http://dx.doi.org/10.2174/1570159X16666180905093535 |
Ejemplares similares
-
Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series
por: Strupp, Michael, et al.
Publicado: (2013) -
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
por: Schniepp, Roman, et al.
Publicado: (2016) -
Acetyl-dl-leucine in cerebellar ataxia ([(18)F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
por: Becker-Bense, Sandra, et al.
Publicado: (2022) -
Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia: The ALCAT Randomized Clinical Crossover Trial
por: Feil, Katharina, et al.
Publicado: (2021) -
Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease
por: Kaya, Ecem, et al.
Publicado: (2020)